As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
His answer is that current evidence does not support the use of medical cannabis for mental illnesses such as anxiety or depression.
[read the full story...]
Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.
[read the full story...]
Inês Pote summarises a recent meta-analysis of randomised placebo-controlled trials of cognitive behavioural therapy for anxiety and related disorders.
[read the full story...]
Carla McEnery appraises a new study that asks: are social and communication difficulties a risk factor for the development of social anxiety?
[read the full story...]
Joe Barnby publishes his debut elf blog on a recent randomised controlled trial of virtual reality compared with in vivo exposure in the treatment of social anxiety disorder.
[read the full story...]
Carla McEnery reports on a recent meta-analysis of technology-assisted interventions for Social Anxiety Disorder, which finds positive results from Internet-delivered CBT and Virtual Reality Exposure Therapy.
[read the full story...]
Chris Sampson looks at a systematic review of the economics of Internet interventions for common mental health problems such as depression and anxiety.
[read the full story...]
Andrew Shepherd appraises a study of the long-term outcomes of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder, which finds both therapies are efficacious in treating social anxiety disorder in the short- and long-term.
[read the full story...]
Social Anxiety Disorder used to be called Social Phobia and is generally regarded as the most prevalent form of common anxiety disorder. Estimates of lifetime prevalence vary but according to a US study, 12% of adults in the US will have social anxiety disorder at some point in their lives (Kessler et al, 2005). According [read the full story…]
Clinical trials in the field of social anxiety to date have primarily focussed on the effect of either anxiolytic medication or cognitive behavioural therapy (CBT). At best these trials have demonstrated only moderate efficacy for either treatment independently (Davidson et al, 2004; Clark et al, 2003; Heimberg et al, 1998; Stein et al, 1998), and [read the full story…]
